
Retatrutide 10mg
Metabolism and weight lossRetatrutide is a research peptide that simultaneously mimics three natural hormones: GLP-1, GIP and glucagon. In the body, these hormones regulate satiety, blood sugar levels and how much energy the body uses. Today it is one of the most studied peptides in metabolism and body-weight research.
Leave your email — we will let you know as soon as the product is in stock.
The independent laboratory's report for the current batch is available on request.
- Form
- Vial
- Payment
- Cash on delivery
- Delivery
- Serbia · 1–3 days · 4 €
- Availability
- Coming soon
- With the vial
- Free bacteriostatic water
- Sequence
- Y-Aib-QGTFTSDYSI-αMeLeu-LDK-Lys(19-carboxy-nonadecanoyl-γGlu-AEEA)-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂
- Molar mass
- 4731.33 g/mol
- CAS number
- 2381089-83-2
1Description
Retatrutide is a synthetic peptide that simultaneously activates three receptors: GLP-1, GIP and glucagon. In clinical research it is studied for its complex effects on glucose metabolism, appetite and thermogenesis. The molecule is designed to mimic three hormones that act in the gut and the brain after a meal: GLP-1 and GIP regulate insulin release and the feeling of fullness, while glucagon influences how much fat is broken down for energy. Because of this triple mechanism, retatrutide is today one of the most studied peptides in research on obesity and metabolic disorders. Packaging: one vial containing 10 mg of lyophilized peptide. 3 ml of bacteriostatic water comes with the vial. 1. Weight loss In a phase 2 clinical trial in adults with obesity, weekly administration of retatrutide at doses of up to 14.7 mg was associated with weight loss of up to 24% of initial body weight after 48 weeks. [1] Compared with dual agonists, the triple mechanism shows a greater percentage of weight loss. [2] 2. Blood sugar metabolism In studies in people with type 2 diabetes and poorly controlled blood sugar levels, retatrutide lowered HbA1c levels, with an additional effect on body weight. [3] 3. Liver fat In a randomized phase 2a trial, retatrutide reduced the percentage of liver fat in people with metabolic dysfunction-associated liver disease. [4] 4. Body composition In a substudy in people with type 2 diabetes, a higher dose of retatrutide was associated with a loss of fat tissue while muscle mass was preserved. [5] References: 1. Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. N Engl J Med, 2023. 2. Tereshchenko A, et al. Systematic review and network meta-analysis of the safety and efficacy of the triple incretin receptor agonist retatrutide. Ther Adv Endocrinol Metab, 2026. 3. Bajaj HS, et al. Efficacy and safety of retatrutide in people with type 2 diabetes and inadequate glycaemic control. Lancet, 2026. 4. Sanyal AJ, et al. Triple hormone receptor agonist retatrutide for MASH: a randomized phase 2a trial. Nat Med, 2024. 5. Coskun T, et al. Effects of retatrutide on body composition in people with type 2 diabetes. Lancet Diabetes Endocrinol, 2025.
2Storage
- Sealed vial: 2–8 °C, in a dry, dark place.
- For long-term storage: -20 °C.
- Before opening, let the vial reach room temperature.
- A few days at room temperature, as long as delivery takes, is not a problem for most peptides.
3Delivery and payment
You pay by cash on delivery: in cash to the courier when you receive the package.
- The package arrives at your address in 1–3 days.
- You pay the postage to the courier on receipt, according to the courier service's price list (shown on the site as 4 €).
- The packaging is plain and discreet, with no indication of the contents.
4Certificate of analysis (COA)
A Certificate of Analysis is a document from an independent laboratory that confirms the identity, purity and mass of the substance in a specific batch. Preporod sends every batch for independent analysis.



